VICKIE L CAPPS
CIK 1248190 · Executive VP, CFO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.72M
Companies
10
Total Filings
64
Lifetime Open-Market Net
$794.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JANX | Director | 79,598 | $15.00 | $1.19M | $0 | 7 | 2026-06-12 |
| OFIX | Director | 43,300 | $12.26 | $530.9K | $62.3K | 4 | 2026-06-12 |
| AMEDISYS INC (AMED) Delisted | Director | 0 | $100.99 | $0 | $187.0K | 9 | 2025-08-14 |
| NUVASIVE INC (NUVA) Delisted | Director | 0 | $39.75 | $0 | $96.5K | 11 | 2023-09-05 |
| OTONOMY, INC. (OTIC) Delisted | Director | 5,000 | $0.08 | $385 | $117.4K | 11 | 2022-11-29 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | 61,576 | $5.87 | $361.5K | $200.0K | 4 | 2022-06-13 |
| Synthorx, Inc. (THOR) Delisted | Director | — | — | — | $0 | 2 | 2020-01-24 |
| CONNECTURE INC (CNXR) Delisted | Director | 136,898 | — | — | $24.1K | 5 | 2017-05-25 |
| SENORX INC (SENO) Delisted | Director | 15,652 | — | — | $72.8K | 5 | 2010-07-07 |
| DJO INC (PXR) Delisted | Executive VP, CFO | 32,837 | — | — | $34.6K | 4 | 2007-05-30 |
Recent Filings · Page 3 of 7
64 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-13 | AMEDISYS INC (AMED) Delisted | Grant (A) | +1,304 | $0 | EDGAR |
| 2022-05-13 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-21 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-24 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | AMEDISYS INC (AMED) Delisted | Grant (A) | +574 | $0 | EDGAR |
| 2021-05-20 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-08 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Buy (P) | +9,523 | $200.0K | EDGAR |
| 2020-12-07 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-10 | NUVASIVE INC (NUVA) Delisted | Buy (P) | +2,000 | $96.5K | EDGAR |
| 2020-06-25 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.